Q2 2026 13F filing
Updated 27 days ago58 disclosed positions worth $1.1B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LQDA LIQUIDIA CORPORATION | $195.1M | 2.45M | 17.67% | — |
| 2 | E ETON ETON PHARMACEUTICALS INC | $103.5M | 2.86M | 9.38% | — |
| 3 | H HROW HARROW INC | $101.9M | 2.40M | 9.23% | — |
| 4 | I IRON DISC MEDICINE INC | $62.5M | 855.0K | 5.66% | — |
| 5 | U URGN UROGEN PHARMA LTD | $53M | 1.44M | 4.80% | — |
| 6 | A APGE APOGEE THERAPEUTICS INC | $51.8M | 390.0K | 4.69% | — |
| 7 | M MGTX MEIRAGTX HLDGS PLC | $48M | 3.55M | 4.34% | — |
| 8 | S SLGL SOL-GEL TECHNOLOGIES LTD | $37.1M | 500.0K | 3.36% | — |
| 9 | R RZLT REZOLUTE INC | $32.8M | 6.30M | 2.97% | — |
| 10 | T TGTX TG THERAPEUTICS INC | $29.4M | 535.0K | 2.66% | — |
| 11 | ? N/A IMMIX BIOPHARMA INC | $24.2M | 2.35M | 2.19% | — |
| 12 | ? N/A CRESCENT BIOPHARMA INC. | $23.7M | 1.32M | 2.15% | — |
| 13 | S STOK STOKE THERAPEUTICS INC | $22.9M | 700.0K | 2.07% | — |
| 14 | A ACOG ALPHA COGNITION INC | $20.9M | 2.90M | 1.89% | — |
| 15 | E EWTX EDGEWISE THERAPEUTICS INC | $20.3M | 500.0K | 1.84% | — |
| 16 | R RVMDW REVOLUTION MEDICINES INC | $18.7M | 100.0K | 1.70% | — |
| 17 | M MNST MONTE ROSA THERAPEUTICS INC | $18M | 745.0K | 1.63% | — |
| 18 | A ALMS ALUMIS INC | $15.5M | 550.0K | 1.40% | — |
| 19 | C CDXS CODEXIS INC | $15.3M | 6.79M | 1.39% | — |
| 20 | Q QCOM REPLIMUNE GROUP INC | $15.3M | 1.38M | 1.39% | — |
| 21 | X XOMAP XOMA ROYALTY CORPORATION | $14.4M | 338.4K | 1.30% | — |
| 22 | M MBX MBX BIOSCIENCES INC | $14.4M | 260.0K | 1.30% | — |
| 23 | R RYTM RHYTHM PHARMACEUTICALS INC | $13.6M | 122.5K | 1.23% | — |
| 24 | E EIX EDITAS MEDICINE INC | $12.5M | 3.86M | 1.13% | — |
| 25 | P PB PROTAGONIST THERAPEUTICS INC | $12.3M | 100.0K | 1.11% | — |
| 26 | C CABA CABALETTA BIO INC | $12M | 3.86M | 1.09% | — |
| 27 | Q QTTB Q32 BIO INC | $11.9M | 931.0K | 1.07% | — |
| 28 | A ANNX ANNEXON INC | $9.8M | 1.71M | 0.89% | — |
| 29 | V VSTM VERASTEM INC | $6.9M | 1.80M | 0.62% | — |
| 30 | ? N/A ZENTALIS PHARMACEUTICALS INC | $6.9M | 1.41M | 0.62% | — |
| 31 | R RLMD RELMADA THERAPEUTICS INC | $6.5M | 935.0K | 0.59% | — |
| 32 | O OCFC OCULAR THERAPEUTIX INC | $5.9M | 600.0K | 0.53% | — |
| 33 | T TRVI TREVI THERAPEUTICS INC | $5.8M | 310.0K | 0.52% | — |
| 34 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $5.3M | 700.0K | 0.48% | — |
| 35 | L LYEL LYELL IMMUNOPHARMA INC | $4.8M | 344.0K | 0.44% | — |
| 36 | I IRD OPUS GENETICS INC | $4.6M | 1.13M | 0.42% | — |
| 37 | F FDMT 4D MOLECULAR THERAPEUTICS IN | $4.4M | 334.4K | 0.40% | — |
| 38 | N NTLA INTELLIA THERAPEUTICS INC | $4.2M | 250.0K | 0.38% | — |
| 39 | ? N/A VOYAGER THERAPEUTICS INC | $4.1M | 1.19M | 0.38% | — |
| 40 | B BDSX BIODESIX INC | $4.1M | 180.0K | 0.37% | — |
| 41 | R RCL ROCKET PHARMACEUTICALS INC | $3.4M | 1.00M | 0.31% | — |
| 42 | J JBIO JADE BIOSCIENCES INC | $3.2M | 145.0K | 0.29% | — |
| 43 | S SNWV SANUWAVE HEALTH INC | $3.1M | 306.1K | 0.28% | — |
| 44 | ? N/A FORTRESS BIOTECH INC | $2.7M | 890.0K | 0.25% | — |
| 45 | D DERM JOURNEY MED CORP | $2.5M | 350.0K | 0.22% | — |
| 46 | P PHAT PHATHOM PHARMACEUTICALS INC | $2M | 185.6K | 0.18% | — |
| 47 | I INBX INHIBRX BIOSCIENCES INC | $1.9M | 20.3K | 0.17% | — |
| 48 | E ENTA ENANTA PHARMACEUTICALS INC | $1.8M | 125.0K | 0.17% | — |
| 49 | C COAG HEMAB THERAPEUTICS HLDGS INC | $1.8M | 47.7K | 0.16% | — |
| 50 | ? N/A FIRST TRACKS BIOTHERAPEUTICS | $1.3M | 65.0K | 0.12% | — |